Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2161 to 2175 of 7707 results

  1. PCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms

      Status ...

    Medical technologies guidance
    Topic selection

  2. Spartan RX point-of-care CYP2C19 test

      Status ...

    Diagnostics guidance
    Topic selection

  3. Healthy.io test for home testing of urine albumin to creatinine ratio

      Status ...

    Diagnostics guidance
    Topic selection

  4. FebriDx for C-reactive protein and myxovirus resistance protein A testing

      Status ...

    Diagnostics guidance
    Topic selection

  5. Helge for detecting haemolysis

      Status ...

    Diagnostics guidance
    Topic selection

  6. MolecuLight i:X for wound imaging

    The panel agreed the technology is not appropriate to be selected for guidance development as there is insufficient evidence.   ...

    Medical technologies guidance
    Topic selection

  7. NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds

      Status ...

    Medical technologies guidance
    Topic selection

  8. Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments [ID6309]

    In development [GID-TA11546] Expected publication date: 10 September 2025

    Technology appraisal guidance
    In development

  9. Suspected cancer update

    In development [GID-QS10176] Expected publication date: TBC

    Quality standard
    In development

  10. Acoramidis for treating transthyretin-mediated amyloidosis cardiomyopathy [ID6354]

    Awaiting development [GID-TA11415] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia when there is no 17p deletion or TP53 mutation and FCR (fludarabine, cyclophosphamide, rituximab) or BR (bendamustine, rituximab) are suitable [ID6291]

    In development [GID-TA11495] Expected publication date: TBC

    Technology appraisal guidance
    In development

  12. An aortic cuff counterpulsation system for the treatment of heart failure

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  13. Extracorporeal bioartificial liver assist therapy

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  14. Chemical Component Separation

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  15. Transnasal endoscopy

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection